Sugi Predict

Sugi Predict / Compounds / SCHEMBL7180544

SCHEMBL7180544

SCHEMBL7180544

CC(C)CP(=O)(C(=O)c1c(C(F)(F)F)cccc1C(F)(F)F)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLQ O75417 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ AKR1C3 P42330 1/20 0.37
▸ AKR1C2 P52895 1/20 0.37
▸ ACP3 P15309 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ TXNRD1 Q16881 1/20 0.36
▸ SLC6A2 P23975 2/20 0.36
▸ SLC6A4 P31645 2/20 0.36
▸ KCNK3 O14649 1/20 0.36
▸ KCNK9 Q9NPC2 1/20 0.36
▸ EPHX2 P34913 3/20 0.36
▸ PPARG P37231 2/20 0.36
▸ F2R P25116 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MRGPRX4 Q96LA9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177862 0.87 ALDH1A1 (0.48) ALDH1A1AKR1C3AKR1C2ACP3HPGD
SCHEMBL27484256 0.86 LMNA (0.44) POLQALDH1A1ACP3HPGDSLC6A2
SCHEMBL7183918 0.86 KCNK3 (0.35) POLQAKR1C3AKR1C2ACP3TXNRD1
SCHEMBL7187317 0.85 GAA (0.41) POLQALDH1A1ACP3HPGDKCNK3
SCHEMBL7184553 0.82 F2R (0.41) ALDH1A1KCNK3KCNK9EPHX2PPARG
SCHEMBL7189797 0.81 TSHR (0.41) ALDH1A1HPGDSLC6A2SLC6A4EPHX2
SCHEMBL7190185 0.81 MRGPRX4 (0.41) ALDH1A1ACP3HPGDTXNRD1KCNK3
SCHEMBL7185540 0.80 ALDH1A1 (0.41) ALDH1A1HPGDSLC6A2SLC6A4F2R
SCHEMBL7175909 0.80 PLK1 (0.42) ALDH1A1HPGDSLC6A2SLC6A4KCNK3
SCHEMBL7175261 0.79 PLK1 (0.44) ALDH1A1HPGDSLC6A2SLC6A4EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 POLQ 1493/4885ALDH1A1 3416/4885AKR1C3 199/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 POLQ 1833/4885ALDH1A1 3984/4885AKR1C3 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.